TCR γδ bearing T lymphocytes infiltrating human primary cutaneous melanomas
暂无分享,去创建一个
[1] R. Demars,et al. Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. , 1990, Science.
[2] A. Bensussan,et al. T lymphocytes bearing the γδ T cell receptor in patients with acute Plasmodium falciparum malaria. , 1990 .
[3] E. Farmer,et al. Distribution of lymphocytes bearing TCRγ/δ in cutaneous lymphocytic infiltrates , 1990 .
[4] L. Dubertret,et al. T-cell receptor-γ/δ bearing lymphocytes in normal and inflammatory human skin , 1990 .
[5] F. Heuźe,et al. Selective expansion of a specific anti‐tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor‐infiltrating lymphocytes from a melanoma patient: Cytotoxic activity and T cell receptor gene rearrangements , 1990, European journal of immunology.
[6] S. Kaufmann,et al. A large fraction of human peripheral blood gamma/delta + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein , 1990, The Journal of experimental medicine.
[7] J. Borst,et al. T-cell receptor γδ bearing cells in normal human skin , 1990 .
[8] K. Meyer zum Büschenfelde,et al. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens , 1989, The Journal of experimental medicine.
[9] S. Tonegawa,et al. Recognition of a self major histocompatibility complex TL region product by gamma delta T-cell receptors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[10] B. Bloom,et al. Lymphocytes bearing antigen-specific γδ T-cell receptors accumulate in human infectious disease lesions , 1989, Nature.
[11] L. Degos,et al. TCR gamma delta bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cells , 1989 .
[12] E. Palmer,et al. Stimulation of a major subset of lymphocytes expressing T cell receptor γδ by an antigen derived from mycobacterium tuberculosis , 1989, Cell.
[13] R. Warnke,et al. Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system , 1989, The Journal of experimental medicine.
[14] L. Lefrançois,et al. In vivo modulation of cytolytic activity and Thy-1 expression in TCR-gamma delta+ intraepithelial lymphocytes. , 1989, Science.
[15] S. Rosenberg,et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. , 1988, The New England journal of medicine.
[16] C. Balch,et al. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor , 1988, The Journal of experimental medicine.
[17] C. Janeway. Frontiers of the immune system , 1988, Nature.
[18] M. Herlyn,et al. Melanoma antigens: immunological and biological characterization and clinical significance. , 1988, Annual review of immunology.
[19] J. Bluestone,et al. Major histocompatibility complex-linked specificity of γδ receptor-bearing T lymphocytes , 1987, Nature.
[20] L. Degos,et al. Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity. , 1987, Journal of Immunology.
[21] W. M. Linehan,et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. , 1987, The New England journal of medicine.
[22] F. Faure,et al. A γ-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity , 1987, Nature.
[23] S. Rosenberg,et al. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. , 1987, Journal of immunology.
[24] I. Bruderman,et al. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. , 1987, Cancer research.
[25] F. Alt,et al. A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes , 1986, Nature.
[26] C. Balch,et al. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. , 1986, Cancer research.
[27] J. Dausset,et al. Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Melamed,et al. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. , 1985, Cancer research.
[29] S. Meuer,et al. A monoclonal antibody that blocks class II histocompatibility-related immune interactions. , 1984, Human immunology.
[30] S. Poppema,et al. Insitu analysis of the mononuclear cell infiltrate in primary malignant-melanoma of the skin , 1983 .
[31] P. Parham,et al. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. , 1982, Journal of immunology.
[32] B. Sugden,et al. Clonal transformation of adult human leukocytes by Epstein-Barr virus , 1977, Journal of virology.